PE
AZN icon

Point72 Europe’s AstraZeneca AZN Stock Holding History

Point72 Europe’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-44,556
Closed -$6.55M – 160
2025
Q1 		$6.55M Buy
+44,556
New +$6.45M 0.45% 73
2024
Q3 		– Sell
-5,498
Closed -$857K – 124
2024
Q2 		$857K Buy
+5,498
New +$827K 0.07% 124

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Point72 Europe's AZN Position: Q2 2025 in Review

Point72 Europe sold out of AstraZeneca (AZN) in Q2 2025, closing a stake of 44,556 shares — an estimated $6.55M sold.

Point72 Europe first reported a position in AZN in Q2 2024 and held it in 2 quarters. The position peaked at $6.55M in Q1 2025. 1,222 funds tracked by Wall St. Rank hold AZN as of Q2 2025.

  • Point72 Europe reported no remaining AstraZeneca position as of Q2 2025 after selling out during the quarter.
  • Point72 Europe sold 44,556 AstraZeneca shares in Q2 2025, an estimated $6.55M.
  • Point72 Europe first reported a position in AstraZeneca in Q2 2024 and held it in 2 quarters.
  • Point72 Europe's AstraZeneca position peaked at $6.55M in Q1 2025.
  • 1,222 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2025.

Based on Point72 Europe's 13F filing for Q2 2025, filed 14 Aug 2025.